Finance1 min read

InCred Equities picks 5 stocks to buy in Samvat 2083, sees up to 46% upside; Artemis, CarTrade Tech among top bets

By · Published by Everything Blog

In short

The brokerage identified Artemis Medicare, CarTrade Tech, RHI Magnesita India, Rolex Rings, and Lemon Tree Hotels as its primary selections for Samvat 2083. Four of these firms feature projected returns greater than 30%, whereas Lemon Tree Hotels is anticipated to climb 23%. Artemis Medicare offers the highest forecasted rise, aided by facility-level efficiencies in Gurugram alongside growth plans in Raipur. Meanwhile, Rolex Rings is anticipated to gain from reviving American export demand, European traction, and domestic sales.

Key points

  • Lemon Tree Hotels targets ₹142 per share supported by an agreement to operate 10 hotel pr…: Lemon Tree Hotels targets ₹142 per share supported by an agreement to operate 10 hotel projects with Omaxe.
  • Rolex Rings is positioned for a 33% advance to ₹251 per share following past disruptions…: Rolex Rings is positioned for a 33% advance to ₹251 per share following past disruptions in export markets.
  • Heavy industrial capital expenditure in Indian steel and cement is anticipated to bolster…: Heavy industrial capital expenditure in Indian steel and cement is anticipated to bolster RHI Magnesita India.

Sources checked by our analysis pipeline: 1

Domestic brokerage firm InCred Equities has identified five stocks to consider buying during the Hindu calendar year Samvat 2083, projecting an average upside potential of around 36% based on its target prices.

The list includes RHI Magnesita India, CarTrade Tech, Artemis Medicare, Rolex Rings, and Lemon Tree Hotels. Of these, the brokerage expects four stocks to deliver gains of more than 30% over the next year, while Lemon Tree Hotels is projected to offer an upside of 23%.

InCred Equities has set a target price of ₹437 per share for Artemis Medicare, indicating an upside potential of 46% from its latest closing price of ₹300.

The brokerage's positive outlook is supported by improving operational performance at its Gurugram facility, while it also sees growth potential from the Raipur facility. Occupancy currently stands at around 10%, with management targeting 20-25% by the end of FY27. InCred expects losses to stabilise over the next 18-24 months.

The company's expansion pipeline includes a 250-bed Tower IV project in Gurugram, scheduled for the second half of FY28, and a proposed 650-plus-bed South Delhi VIMHANS…

Finance